awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33938441-4C4DA90B-577A-42D2-AA79-BF5CD298BA7E
Q33938441-4C4DA90B-577A-42D2-AA79-BF5CD298BA7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33938441-4C4DA90B-577A-42D2-AA79-BF5CD298BA7E
Drug resistance to molecular targeted therapy and its consequences for treatment decisions in non-small-cell lung cancer.
P2860
Q33938441-4C4DA90B-577A-42D2-AA79-BF5CD298BA7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33938441-4C4DA90B-577A-42D2-AA79-BF5CD298BA7E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ee4ebdebd16c57f9513f5da31a262fe45d74b213
P2860
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.